
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Zealand Pharma
Market Cap: DKK 19.7b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 280.60
7D
-8.3%
1Y
-23.9%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 175.50
7D
-4.7%
1Y
0.8%